2nd Quarter - Report

STANTON PARK GROUP for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Raising awareness of Hepatitis C (no specific bills); Access to rare and orphan disease therapeutics under the enactment of ACA (no specific bills); FDA regulatory pathways for pharmaceuticals (no specific bills); H.R. 460 The Patients' Access to Treatments Act of 2013 (all provisions). Awareness of Cystic Fibrosis (no specific bills)

LobbyistCovered position, as disclosed
JAMES DERDERIAN —
VALERIE HENRY —
PATRICK LYDEN —
RICHARD MATHER RUSSELL —
ERIN STRAWN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 460 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.